Sign in / Join Now
ETFs & Funds
Cubist Pharmaceuticals to Acquire Adolor for $190 million or $4.25 per share in cash $
Add a reply...
Latest StockTalks »
people get MRK breaking news and analysis by email alert.
Get email alerts on MRK »
Merck & Co Inc.
Get latest price
From other sites
Buy Merck on Near-Term Weakness
at TheStreet (Fri, 11:36AM)
Merck (MRK) Updates Outlook Following Q2 Earnings Beat
at Zacks.com (Fri, 10:14AM)
Merck (MRK) Beats on Q2 Earnings by a Penny
at Zacks.com (Fri, 8:18AM)
Investors Greet Merck Q2 Results As Key Launches Help Beat
at Benzinga (Fri, 7:45AM)
Merck Shares Rise After Second-Quarter Earnings Top Forecasts
at TheStreet (Fri, 7:34AM)